Vaccination

What's at stake in COVID-19 jab patent waiver row

Over a year into global COVID-19 vaccination efforts the question of whether jab formulas ought to be freely available is still unresolved—and undersupplied countries are turning to workarounds.

Oncology & Cancer

Research suggests possibility of vaccine to prevent skin cancer

Research by the Oregon State University College of Pharmacy suggests that a vaccine stimulating production of a protein critical to the skin's antioxidant network could help people bolster their defenses against skin cancer.

Diseases, Conditions, Syndromes

Pfizer/BioNTech to develop mRNA-based shingles shot

Germany's BioNTech and US pharma giant Pfizer, which together developed a COVID-19 vaccine in record time, said Wednesday they are working on a shingles shot using the same mRNA technology.

Diseases, Conditions, Syndromes

What makes an mRNA vaccine so effective against severe COVID-19?

The first two vaccines created with mRNA vaccine technology—the Pfizer/BioNTech and Moderna COVID-19 vaccines—are arguably two of the most effective COVID vaccines developed to date. In clinical trials, both were more ...

Diseases, Conditions, Syndromes

Novavax COVID-19 vaccine found to be safe and effective

An investigational COVID-19 vaccine made by Novavax was found to be 90 percent effective at preventing COVID-19 illness, according to results from a Phase 3 clinical trial published today in the New England Journal of Medicine. ...

page 1 from 40